IQVIA Holdings Inc. logo
IQVIA Holdings Inc. (IQV)
Compare

IQVIA Holdings Inc. (IQV) Quick Ratio (Acid-Test): 0.75

Is IQVIA Holdings Inc.’s quick ratio (acid-test) high or low?

IQVIA Holdings Inc.'s quick ratio (acid-test) of 0.75 is 16% below its 5-year average of 0.90, near the low end of its 5-year range (0.75–1.12).

The quick ratio (acid-test) for IQVIA Holdings Inc. (IQV) is 0.75 as of Wednesday, June 10, 2026. It is below its 12-month average by 5.66% (0.79).

IQV Quick Ratio (Acid-Test) Chart

IQV Quick Ratio (Acid-Test)
0.75-10.71% 1Y
Zoom

IQV Average Quick Ratio (Acid-Test) Chart

IQV Current vs Average Quick Ratio (Acid-Test) Chart

IQV Quick Ratio (Acid-Test) Metrics

QUICK RATIO (ACID-TEST)

0.75

QUICK RATIO (ACID-TEST) AVG TTM

0.79

QUICK RATIO (ACID-TEST) AVG 3Y

0.83

QUICK RATIO (ACID-TEST) AVG 5Y

0.90

QUICK RATIO (ACID-TEST) AVG 10Y

1.04

QUICK RATIO (ACID-TEST) AVG 15Y

1.10

QUICK RATIO (ACID-TEST) AVG 20Y

1.10

CURRENT VS TTM AVG

-5.66%

CURRENT VS 3Y AVG

-10.18%

CURRENT VS 5Y AVG

-16.20%

CURRENT VS 10Y AVG

-28.14%

CURRENT VS 15Y AVG

-32.02%

CURRENT VS 20Y AVG

-32.02%

IQV Competitors' Quick Ratio (Acid-Test)

NAMEMARKET CAPQUICK RATIO (ACID-TEST)TTM3Y5Y
IQVIA Holdings Inc. (IQV)$30.60B0.750.790.830.90
Medline Inc. (MDLN)$30.90B2.371.972.092.09
Centene Corporation (CNC)$31.94B1.681.401.241.19
DexCom, Inc. (DXCM)$29.24B1.591.441.802.83
Biogen Inc. (BIIB)$29.00B2.031.461.691.64
Zoetis Inc. (ZTS)$34.20B1.941.511.661.96
Veeva Systems Inc. (VEEV)$26.73B4.894.704.394.08
Agilent Technologies, Inc. (A)$37.17B1.521.541.631.68
Waters Corporation (WAT)$23.83B1.271.391.501.54
Mettler-Toledo International Inc. (MTD)$22.85B0.810.770.770.79

Liquidity Comparison

Quick Ratio

0.75

Excludes inventory

Current Ratio

0.75

Includes inventory

IQVIA Holdings Inc. Quick Ratio (Acid-Test) Formula & Definition

Quick Ratio = (Current Assets − Inventory) / Current Liabilities

The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

IQVIA Holdings Inc. Quick Ratio (Acid-Test) FAQ

What is the quick ratio (acid-test) for IQVIA Holdings Inc. (IQV)?
The quick ratio (acid-test) for IQV stock is 0.75.
Is IQVIA Holdings Inc.'s quick ratio (acid-test) high or low?
IQVIA Holdings Inc.'s quick ratio (acid-test) of 0.75 is 16% below its 5-year average of 0.90, near the low end of its 5-year range (0.75–1.12).
What is the TTM average quick ratio (acid-test) for IQVIA Holdings Inc. (IQV)?
The TTM average quick ratio (acid-test) for IQV stock is 0.79.
What is the 3Y average quick ratio (acid-test) for IQVIA Holdings Inc. (IQV)?
The 3Y average quick ratio (acid-test) for IQV stock is 0.83.
What is the 5Y average quick ratio (acid-test) for IQVIA Holdings Inc. (IQV)?
The 5Y average quick ratio (acid-test) for IQV stock is 0.90.
What is the 10Y average quick ratio (acid-test) for IQVIA Holdings Inc. (IQV)?
The 10Y average quick ratio (acid-test) for IQV stock is 1.04.
What is the 15Y average quick ratio (acid-test) for IQVIA Holdings Inc. (IQV)?
The 15Y average quick ratio (acid-test) for IQV stock is 1.10.
What is the 20Y average quick ratio (acid-test) for IQVIA Holdings Inc. (IQV)?
The 20Y average quick ratio (acid-test) for IQV stock is 1.10.

IQVIA Holdings Inc. Quick Ratio (Acid-Test) History

DATEQUICK RATIO (ACID-TEST)
2025-12-310.75
2024-12-310.84
2023-12-310.86
2022-12-310.89
2021-12-310.91
2020-12-311.12
2019-12-311.05
2018-12-311.10
2017-12-311.22
2016-12-311.23
2015-12-311.51
2014-12-311.46
2013-12-311.31
2012-12-311.15
2011-12-311.15

About IQVIA Holdings Inc.

IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.

Durham, NC
89,000 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Ari Bousbib